Complement involvement in kidney diseases: From physiopathology to therapeutical targeting

doi:10.5527/wjn.v4.i2.169

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9379)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

583

WORD

326

HTML

5910

Figures (1-4)

279

Tables (1-3)

184

Sum=7282

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

887

Download

1210

Sum=2097

May 6, 2015 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Nephrology

ISSN

2220-6124

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Nephrol. May 6, 2015; 4(2): 169-184
Published online May 6, 2015. doi: 10.5527/wjn.v4.i2.169

Table 1 Representative abnormalities in complement leading to renal disease

Components/related molecules	Diseases
Complement C3	C3 glomerulopathy (DDD), aHUS
Factor H	C3 glomerulopathy (DDD/C3GN), aHUS
Factor I	C3 glomerulopathy (C3GN), aHUS
MCP	aHUS
Factor B	aHUS
CFHR5	Familial C3 glomerulopathy (CFHR5 nepropathy)
CFHR3-1	Familial C3 glomerulopathy
CFHR1/3	IgA nephropathy, aHUS
Factor B autoantibody	C3 glomerulopathy (DDD)
Factor H autoantibody	C3 glomerulopathy (DDD/C3GN)
Bb (activated factor B)	HUS, ANCA-associated vasculitis
C3Nef	C3 glomerulopathy (DDD, C3GN)
Soluble C5b-9	HUS, TTP, ANCA-associated vasculitis
C3a	ANCA-associated vasculitis, TTP
C5a	ANCA-associated vasculitis
C1q/C1qR	C1q nephropathy
Properdin	TI injury due to massive proteinuria
C5	ANCA-associated vasculitis
Factor B	ANCA-associated vasculitis
CRaR	TI inflammation, IRI
C5aR	IRI
Factor H	IRI
C5b-9	IRI
CD59	IRI

DDD: Dense deposit disease; aHUS: Atypical hemolytic uremic syndrome; C3GN: C3 glomerulonephritis; MCP: Membrane co-factor protein; CFHR5: Complement factor H-related protein; ANCA: Anti neutrophil cytoplasmic antibody; C3Nef: C3 nephritic factor; TTP: Thrombotic thrombocytopenic purpura; TI: Tubulo-interstitial; IRI: Ischemia-reperfusion-injury.

Citation: Salvadori M, Rosso G, Bertoni E. Complement involvement in kidney diseases: From physiopathology to therapeutical targeting. World J Nephrol 2015; 4(2): 169-184
URL: https://www.wjgnet.com/2220-6124/full/v4/i2/169.htm
DOI: https://dx.doi.org/10.5527/wjn.v4.i2.169